Basic Information
RNALocate ID: RLID:11001781
RNA Symbol: hsa-miR-142-5p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-142-5p
RNA ID: miRBase:MIMAT0000433
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 23382797
Tissue/Cell Line: Brain tissue
Method: Microarray
Description: We performed miRNA expression analysis using a FlexMAP3D instrument by (Luminex Corporation, Austin, TX) and a manufacturer's assay for 312 miRNA (Table S1). Data are collected from Table S1.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001785 Endoplasmic reticulum membrane Cortical tissue 32451872
RLID:11001776 Exosome Bronchoalveolar lavage fluid|Pooled sera 27278097
RLID:11001777 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11001778 Exosome Renal cancer cells 21670082
RLID:11001779 Exosome HCC cell line (Hep3B|HepG2|PLC/PRF/5) 21721029
RLID:11001780 Exosome Breast milk 22211110
RLID:11001782 Exosome Plasma 23663360
RLID:11001783 Exosome Human mast cell line (HMC-1) 24009880
RLID:11001785 Microvesicle Liver resident stem cells 20668554
RLID:11001786 Microvesicle Plasma 23077538
RLID-D:11000083 Exosome Blood|B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Lymphoma tissue|Mast cells
RLID-D:11000361 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-142-5p Mantle cell lymphoma MNDR-E-MI-14022
MNDR hsa-miR-142-5p Splenic marginal zone lymphoma MNDR-E-MI-14023
MNDR hsa-miR-142-5p Multiple sclerosis chronic progressive MNDR-E-MI-14024
MNDR hsa-miR-142-5p Oral squamous cell carcinoma MNDR-E-MI-14025
MNDR hsa-miR-142-5p Medulloblastoma MNDR-E-MI-14026
MNDR hsa-miR-142-5p Malt lymphoma MNDR-E-MI-14027
MNDR hsa-miR-142-5p Uterine corpus endometrial carcinoma MNDR-E-MI-14028
MNDR hsa-miR-142-5p Lymphoma MNDR-E-MI-14029
MNDR hsa-miR-142-5p Lymphoma non-hodgkin MNDR-E-MI-14030
MNDR hsa-miR-142-5p Estrogen-receptor positive breast cancer MNDR-E-MI-14031
MNDR hsa-miR-142-5p Estrogen-receptor negative breast cancer MNDR-E-MI-14032
MNDR hsa-miR-142-5p Progesterone-receptor positive breast cancer MNDR-E-MI-14033
MNDR hsa-miR-142-5p Progesterone-receptor negative breast cancer MNDR-E-MI-14034
MNDR hsa-miR-142-5p Her2-receptor positive breast cancer MNDR-E-MI-14035
MNDR hsa-miR-142-5p Breast cancer luminal MNDR-E-MI-14036
MNDR hsa-miR-142-5p Lupus nephritis MNDR-E-MI-14037
MNDR hsa-miR-142-5p Dermatomyositis MNDR-E-MI-14038
MNDR hsa-miR-142-5p Prostate cancer MNDR-E-MI-14039
MNDR hsa-miR-142-5p Hirschsprung disease MNDR-E-MI-14040
MNDR hsa-miR-142-5p Gastric lymphoma MNDR-E-MI-14041
MNDR hsa-miR-142-5p Alzheimer disease MNDR-E-MI-14042
MNDR hsa-miR-142-5p Intracranial aneurysm MNDR-E-MI-14043
MNDR hsa-miR-142-5p Esophageal carcinoma MNDR-E-MI-14044
MNDR hsa-miR-142-5p Head and neck cancer MNDR-E-MI-14045
MNDR hsa-miR-142-5p Malaria MNDR-E-MI-14046
MNDR hsa-miR-142-5p Leukemia MNDR-E-MI-14047
MNDR hsa-miR-142-5p Huntington disease MNDR-E-MI-14048
MNDR hsa-miR-142-5p Chorea MNDR-E-MI-14049
MNDR hsa-miR-142-5p Cardiovascular disease MNDR-E-MI-14050
MNDR hsa-miR-142-5p Lung cancer MNDR-E-MI-14051
MNDR hsa-miR-142-5p Parkinson disease MNDR-E-MI-14052
MNDR hsa-miR-142-5p Machado-joseph disease MNDR-E-MI-14053
MNDR hsa-miR-142-5p Basal-like breast cancer MNDR-E-MI-14054
MNDR hsa-miR-142-5p Pancreatic cancer MNDR-E-MI-14055
MNDR hsa-miR-142-5p Melanoma MNDR-E-MI-14056
MNDR hsa-miR-142-5p Rectum adenocarcinoma MNDR-E-MI-14057
MNDR hsa-miR-142-5p Nephroblastoma MNDR-E-MI-14058
MNDR hsa-miR-142-5p Colon cancer MNDR-E-MI-14059
MNDR hsa-miR-142-5p Colon adenocarcinoma MNDR-E-MI-14060
MNDR hsa-miR-142-5p Relapsing-remitting multiple sclerosis MNDR-E-MI-14061
MNDR hsa-miR-142-5p Familial ovarian cancer MNDR-E-MI-14062
MNDR hsa-miR-142-5p Carcinoma ductal breast MNDR-E-MI-14063
MNDR hsa-miR-142-5p Glioblastoma MNDR-E-MI-14064
MNDR hsa-miR-142-5p Malignant glioma MNDR-E-MI-14065
MNDR hsa-miR-142-5p Amyotrophic lateral sclerosis MNDR-E-MI-14066
MNDR hsa-miR-142-5p Osteosarcoma MNDR-E-MI-14067
MNDR hsa-miR-142-5p Inclusion body myositis MNDR-E-MI-14068
MNDR hsa-miR-142-5p Breast carcinoma MNDR-E-MI-14069
MNDR hsa-miR-142-5p Pancreatic ductal adenocarcinoma MNDR-E-MI-14070
MNDR hsa-miR-142-5p Meningioma MNDR-E-MI-14071
MNDR hsa-miR-142-5p Uterine cancer MNDR-E-MI-14072
MNDR hsa-miR-142-5p Gastric adenocarcinoma MNDR-E-MI-14073
MNDR hsa-miR-142-5p Cervical squamous cell carcinoma MNDR-E-MI-14074
MNDR hsa-miR-142-5p Lung squamous cell carcinoma MNDR-E-MI-14075
MNDR hsa-miR-142-5p Non-small cell lung cancer MNDR-E-MI-14076
MNDR hsa-miR-142-5p Lung adenocarcinoma MNDR-E-MI-14077
MNDR hsa-miR-142-5p Adrenocortical carcinoma MNDR-E-MI-14078
MNDR hsa-miR-142-5p Thyroid carcinoma MNDR-E-MI-14079
MNDR hsa-miR-142-5p Pancreatic adenocarcinoma MNDR-E-MI-14080
MNDR hsa-miR-142-5p Myasthenia gravis autoimmune experimental MNDR-E-MI-14081
MNDR hsa-miR-142-5p Carcinoma renal cell MNDR-E-MI-14082
MNDR hsa-miR-142-5p Kidney renal papillary cell carcinoma MNDR-E-MI-14083
MNDR hsa-miR-142-5p Clear cell renal cell cancer MNDR-E-MI-14084
MNDR hsa-miR-142-5p Cholangiocarcinoma MNDR-E-MI-14085
MNDR hsa-miR-142-5p Esophageal cancer MNDR-E-MI-14086
MNDR hsa-miR-142-5p Lung small cell carcinoma MNDR-E-MI-14087
MNDR hsa-miR-142-5p Testicular germ cell cancer MNDR-E-MI-14088
MNDR hsa-miR-142-5p Kidney diseases MNDR-E-MI-14089
MNDR hsa-miR-142-5p Breast invasive carcinoma MNDR-E-MI-14090
MNDR hsa-miR-142-5p Hepatocellular carcinoma MNDR-E-MI-14091
MNDR hsa-miR-142-5p Familiar ovarian carcinoma MNDR-E-MI-14092
MNDR hsa-miR-142-5p B-cell lymphoma MNDR-E-MI-14093
MNDR hsa-miR-142-5p Rheumatoid arthritis MNDR-E-MI-14094
MNDR hsa-miR-142-5p T-cell leukemia MNDR-E-MI-14095
MNDR hsa-miR-142-5p Retinoblastoma MNDR-E-MI-14096
MNDR hsa-miR-142-5p Barrett's adenocarcinoma MNDR-E-MI-14097
MNDR hsa-miR-142-5p Chronic fatigue syndrome MNDR-E-MI-14098
MNDR hsa-miR-142-5p Hodgkin lymphoma MNDR-E-MI-14099
MNDR hsa-miR-142-5p Ulcerative colitis MNDR-E-MI-14100
MNDR hsa-miR-142-5p Burkitt lymphoma MNDR-E-MI-14101
MNDR hsa-miR-142-5p Dementia vascular MNDR-E-MI-14102
MNDR hsa-miR-142-5p Tonsil cancer MNDR-E-MI-14103
MNDR hsa-miR-142-5p Neuromyelitis optica MNDR-E-MI-14104
MNDR hsa-miR-142-5p Skin cutaneous melanoma MNDR-E-MI-14105
MNDR hsa-miR-142-5p Skin melanoma MNDR-E-MI-14106
MNDR hsa-miR-142-5p Acute myeloid leukemia MNDR-E-MI-14107
MNDR hsa-miR-142-5p Colorectal cancer MNDR-E-MI-14108
MNDR hsa-miR-142-5p Nasopharynx carcinoma MNDR-E-MI-14109
MNDR hsa-miR-142-5p Multiple myeloma MNDR-E-MI-14110
MNDR hsa-miR-142-5p Fever MNDR-E-MI-14111
MNDR hsa-miR-142-5p Cardiac hypertrophy MNDR-E-MI-14112
MNDR hsa-miR-142-5p Nasopharyngeal cancer MNDR-E-MI-14113
MNDR hsa-miR-142-5p Aids dementia complex MNDR-E-MI-14114
MNDR hsa-miR-142-5p Stroke lacunar MNDR-E-MI-14115
MNDR hsa-miR-142-5p Barrett's carcinogenesis MNDR-E-MI-14116
MNDR hsa-miR-142-5p Breast cancer her3+ negative MNDR-E-MI-14117
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter AGER Homo sapiens RR00054545
TOP